Large-scale population study out of South Korea has now found a 27% overall increase in cancer linked to the COVID-19 injections

[DonGlock26]

"1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea
Hong Jin Kim, Min-Ho Kim, Myeong Geun Choi & Eun Mi Chun


Biomarker Research volume 13, Article number: 114 (2025) Cite this article

102k Accesses

2572 Altmetric

Metricsdetails

Abstract

The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent risks of overall cancers 1 year after COVID-19 vaccination. Data from 8,407,849 individuals between 2021 and 2023 were obtained from the Korean National Health Insurance database. The participants were categorized into two groups based on their COVID-19 vaccination status. The risks for overall cancer were assessed using multivariable Cox proportional hazards models, and data were expressed as hazard ratios (HRs) and 95% confidence intervals (CIs). The HRs of thyroid (HR, 1.351; 95% CI, 1.206–1.514), gastric (HR, 1.335; 95% CI, 1.130–1.576), colorectal (HR, 1.283; 95% CI, 1.122–1.468), lung (HR, 1.533; 95% CI, 1.254–1.874), breast (HR, 1.197; 95% CI, 1.069–1.340), and prostate (HR, 1.687; 95% CI, 1.348–2.111) cancers significantly increased at 1 year post-vaccination. In terms of vaccine type, cDNA vaccines were associated with the increased risks of thyroid, gastric, colorectal, lung, and prostate cancers; mRNA vaccines were linked to the increased risks of thyroid, colorectal, lung, and breast cancers; and heterologous vaccination was related to the increased risks of thyroid and breast cancers. Given the observed associations between COVID-19 vaccination and cancer incidence by age, sex, and vaccine type, further research is needed to determine whether specific vaccination strategies may be optimal for populations in need of COVID-19 vaccination."

1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea - Biomarker Research

The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent...

biomarkerres.biomedcentral.com

Trust the science, right? If this is true, who is going to pay?

 

[Blaster]

The jab is bad news.

 

[shockedcanadian]

If this were true it would suggest it does something to increase cell replication.

 

[DonGlock26]

If this were true it would suggest it does something to increase cell replication.

It's one big science experiment. This time researchers used live sheep.

 

[skye]

Its horrible what they have done to humanity!


"The study used data from 2021–2023 for over 8.4 million people in South Korea’s National Health Insurance Service database. The sample was split into two groups based on vaccination status. The vaccinated sample was further split into booster and non-booster groups.

Researchers tracked the patients for one year. The vaccinated group was tracked following vaccination. The results showed a statistically significant higher risk of cancer in the vaccinated group, including:

• Overall cancer: 27% higher risk

• Breast cancer: 20% higher risk

• Colorectal cancer: 28% higher risk

• Gastric cancer: 34% higher risk

• Lung cancer: 53% higher risk

• Prostate cancer: 69% higher risk

• Thyroid cancer: 35% higher risk

 

[justoffal]

"1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea
Hong Jin Kim, Min-Ho Kim, Myeong Geun Choi & Eun Mi Chun


Biomarker Research volume 13, Article number: 114 (2025) Cite this article

102k Accesses

2572 Altmetric

Metricsdetails

Abstract

The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent risks of overall cancers 1 year after COVID-19 vaccination. Data from 8,407,849 individuals between 2021 and 2023 were obtained from the Korean National Health Insurance database. The participants were categorized into two groups based on their COVID-19 vaccination status. The risks for overall cancer were assessed using multivariable Cox proportional hazards models, and data were expressed as hazard ratios (HRs) and 95% confidence intervals (CIs). The HRs of thyroid (HR, 1.351; 95% CI, 1.206–1.514), gastric (HR, 1.335; 95% CI, 1.130–1.576), colorectal (HR, 1.283; 95% CI, 1.122–1.468), lung (HR, 1.533; 95% CI, 1.254–1.874), breast (HR, 1.197; 95% CI, 1.069–1.340), and prostate (HR, 1.687; 95% CI, 1.348–2.111) cancers significantly increased at 1 year post-vaccination. In terms of vaccine type, cDNA vaccines were associated with the increased risks of thyroid, gastric, colorectal, lung, and prostate cancers; mRNA vaccines were linked to the increased risks of thyroid, colorectal, lung, and breast cancers; and heterologous vaccination was related to the increased risks of thyroid and breast cancers. Given the observed associations between COVID-19 vaccination and cancer incidence by age, sex, and vaccine type, further research is needed to determine whether specific vaccination strategies may be optimal for populations in need of COVID-19 vaccination."

1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea - Biomarker Research

The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent...

biomarkerres.biomedcentral.com

Trust the science, right? If this is true, who is going to pay?

The death shot.....

WEF feels like the world is overpopulated

 

[PeterPilot]

The jab is bad news.

The jab is a biological weapon.

 

[DonGlock26]

I'd just like to take this opportunity to remind progressives to get their Covid mRNA
booster this fall.